摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-Carboxymethyl-phenylamino)-quinoxaline-2-carboxylic acid | 476374-10-4

中文名称
——
中文别名
——
英文名称
3-(4-Carboxymethyl-phenylamino)-quinoxaline-2-carboxylic acid
英文别名
3-[4-(Carboxymethyl)anilino]quinoxaline-2-carboxylic acid
3-(4-Carboxymethyl-phenylamino)-quinoxaline-2-carboxylic acid化学式
CAS
476374-10-4
化学式
C17H13N3O4
mdl
——
分子量
323.308
InChiKey
YDXHXRJBDDRQCU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    112
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(4-Carboxymethyl-phenylamino)-quinoxaline-2-carboxylic acidsodium hydroxide氰基磷酸二乙酯三乙胺 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 (S)-2-{2-[4-(3-Carboxy-quinoxalin-2-ylamino)-phenyl]-acetylamino}-pentanedioic acid
    参考文献:
    名称:
    Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-l-glutamates as analogues–homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity
    摘要:
    Among a new series of 26 4-(3-substituted-2-quinoxalylamino)phenylacetates and 4-(3-substituted-2-quinoxalylamino)-phenylacetyl-L-glutamates, eight were selected at NO for evaluation of their in vitro anticancer activity. The results obtained in comparison with the corresponding nor-compounds series seem to indicate that this type of homologation is not helpful. (C) 2002 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01159-4
  • 作为产物:
    参考文献:
    名称:
    Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-l-glutamates as analogues–homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity
    摘要:
    Among a new series of 26 4-(3-substituted-2-quinoxalylamino)phenylacetates and 4-(3-substituted-2-quinoxalylamino)-phenylacetyl-L-glutamates, eight were selected at NO for evaluation of their in vitro anticancer activity. The results obtained in comparison with the corresponding nor-compounds series seem to indicate that this type of homologation is not helpful. (C) 2002 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01159-4
点击查看最新优质反应信息